Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-21 5:05 pm Unchanged |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Barclays PLC | 3,949,801 8.870% |
0 (Unchanged) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 4,523,184 9.990% |
470,980 (+11.62%) |
Filing History |
| 2025-02-14 4:26 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,706,551 9.990% |
427,030 (+9.98%) |
Filing History |
| 2025-02-14 4:22 pm Sale |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Alyeska Investment Group, L.P. | 1,000,000 2.100% |
-1,859,954 (-65.03%) |
Filing History |
| 2025-02-14 2:26 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Barclays PLC | 3,949,801 8.870% |
3,949,801 (New Position) |
Filing History |
| 2025-02-14 07:27 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
BALYASNY ASSET MANAGEMENT LLC | 3,945,927 8.870% |
3,945,927 (New Position) |
Filing History |
| 2025-02-13 12:32 pm Sale |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management, LLC | 2,203,333 4.800% |
-440,287 (-16.65%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 3,350,692 7.300% |
1,925,058 (+135.03%) |
Filing History |
| 2025-01-31 10:08 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
The Vanguard Group | 2,311,514 5.190% |
2,311,514 (New Position) |
Filing History |
| 2025-01-21 11:57 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
HIRSCHMAN ORIN | 2,717,827 6.100% |
2,717,827 (New Position) |
Filing History |
| 2024-11-14 6:25 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 4,148,862 9.900% |
2,619,747 (+171.32%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 4,052,204 9.990% |
4,052,204 (New Position) |
Filing History |
| 2024-11-14 4:38 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% |
1,662,119 (+63.50%) |
Filing History |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Alyeska Investment Group, L.P. | 2,859,954 7.110% |
2,859,954 (New Position) |
Filing History |
| 2024-11-14 4:30 pm Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,531,829 (Position Closed) |
Filing History |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Soleus Private Equity Fund III L.P. | 3,994,629 8.700% |
3,994,629 (New Position) |
Filing History |
| 2024-11-14 09:02 am Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Flynn James E | 0 0.000% |
-1,538,461 (Position Closed) |
Filing History |
| 2024-11-13 5:39 pm Sale |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management, LLC | 2,643,620 6.400% |
-23,046 (-0.86%) |
Filing History |
| 2024-11-12 09:35 am Unchanged |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Adage Capital Management L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BLACKROCK INC BLK |
2,234,699 5.600% |
0 (Unchanged) |
Filing History |